Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP528731.RAx3hv8gSHgijlW0vIX8SS7f0rFEdMi7YcWe_3dSVS8s8130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP528731.RAx3hv8gSHgijlW0vIX8SS7f0rFEdMi7YcWe_3dSVS8s8130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP528731.RAx3hv8gSHgijlW0vIX8SS7f0rFEdMi7YcWe_3dSVS8s8130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP528731.RAx3hv8gSHgijlW0vIX8SS7f0rFEdMi7YcWe_3dSVS8s8130_provenance.
- befree-2016 importedOn "2016-02-19" NP528731.RAx3hv8gSHgijlW0vIX8SS7f0rFEdMi7YcWe_3dSVS8s8130_provenance.
- NP528731.RAx3hv8gSHgijlW0vIX8SS7f0rFEdMi7YcWe_3dSVS8s8130_assertion wasGeneratedBy ECO_0000203 NP528731.RAx3hv8gSHgijlW0vIX8SS7f0rFEdMi7YcWe_3dSVS8s8130_provenance.
- NP528731.RAx3hv8gSHgijlW0vIX8SS7f0rFEdMi7YcWe_3dSVS8s8130_assertion wasDerivedFrom befree-2016 NP528731.RAx3hv8gSHgijlW0vIX8SS7f0rFEdMi7YcWe_3dSVS8s8130_provenance.
- NP528731.RAx3hv8gSHgijlW0vIX8SS7f0rFEdMi7YcWe_3dSVS8s8130_assertion SIO_000772 16381942 NP528731.RAx3hv8gSHgijlW0vIX8SS7f0rFEdMi7YcWe_3dSVS8s8130_provenance.
- NP528731.RAx3hv8gSHgijlW0vIX8SS7f0rFEdMi7YcWe_3dSVS8s8130_assertion evidence source_evidence_literature NP528731.RAx3hv8gSHgijlW0vIX8SS7f0rFEdMi7YcWe_3dSVS8s8130_provenance.
- NP528731.RAx3hv8gSHgijlW0vIX8SS7f0rFEdMi7YcWe_3dSVS8s8130_assertion description "[Tumor-associated antigens (TAAs) have been the most actively employed targets in the clinical diagnosis and treatment of human carcinoma, such as PSA in the diagnosis of prostate cancer and NY-ESO-1 in the immunotherapy of melanoma and other cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP528731.RAx3hv8gSHgijlW0vIX8SS7f0rFEdMi7YcWe_3dSVS8s8130_provenance.